Media Kit: Access to New Medicines Report

Report: Access to New Medicines in the United States vs. Other High-income Countries

May 13, 2026

https://cdn.aglty.io/phrma/PhRMA_OnePager_AccessToNewMedicinesReport_8.5x11_v3.2_Print (2)_20260513104421.pdf

Graphic: Share of New Medicines Reimbursed by Public Insurance

May 13, 2026

https://cdn.aglty.io/phrma/Share of New Medicines Reimbursed by Public Insurance for All vs Some Approved Indications_20260512110524.pdf

Graphic: Average Number of Months from Global First Launch to Public Reimbursement

May 13, 2026

https://cdn.aglty.io/phrma/Average Number of Months from Global First Launch to Oublic Insurance Reimbursement_20260513102106.pdf

Graphic: Spending on New Medicines as a Share of GDP

May 13, 2026

https://cdn.aglty.io/phrma/Spending on New Medicines as a Share of GDP Bar Graph_20260513114359.pdf

Graphic: Share of New Medicines Reimbursed by Public Insurance for All vs. Some Approved Indications

May 13, 2026

https://cdn.aglty.io/phrma/Share of New Medicines Reimbursed by Public Insurance for All vs. Some Approved Indications_20260513114130.pdf

Graphic: Patients in Other Countries

May 13, 2026

https://cdn.aglty.io/phrma/Patients in other countries_20260512105046.pdf

Graphic: Share of New Medicines Reimbursed by Public Insurance by Therapy Area

May 13, 2026

https://cdn.aglty.io/phrma/Share of New Medicines Reimbursed by Public Insurance by Therapy Area_20260512111410.pdf